Afroditi Karathanasi

963 total citations
16 papers, 724 citations indexed

About

Afroditi Karathanasi is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, Afroditi Karathanasi has authored 16 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Reproductive Medicine and 5 papers in Surgery. Recurrent topics in Afroditi Karathanasi's work include Ovarian cancer diagnosis and treatment (7 papers), PARP inhibition in cancer therapy (6 papers) and Management of metastatic bone disease (4 papers). Afroditi Karathanasi is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), PARP inhibition in cancer therapy (6 papers) and Management of metastatic bone disease (4 papers). Afroditi Karathanasi collaborates with scholars based in United Kingdom, Greece and France. Afroditi Karathanasi's co-authors include Stergios Boussios, Nicholas Pavlidis, Michele Moschetta, Elie Rassy, Peeter Karihtala, Matin Sheriff, Charlotte Abson, Mehmet Akif Öztürk, Deirdre Cooke and Konstantinos H. Katsanos and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Environmental Research and Public Health and Cancers.

In The Last Decade

Afroditi Karathanasi

16 papers receiving 717 citations

Peers

Afroditi Karathanasi

ONCOL

SURGE

PFM

Georgia A. McCann United States

Rong‐Miao Zhou China

Alexandre André Balieiro Anastácio da Costa Brazil

Gloria Mittica Italy

Yoshimichi Tanaka Japan

Sophie Barrett United Kingdom

Satoe Fujiwara Japan

J. M. G. Bonfrer Netherlands

Xi Cheng China

Satoru Nakayama Japan

Georgia A. McCann United States

Afroditi Karathanasi

554 ×1.3

ONCOL

250 ×1.0

139 ×0.6

98 ×0.8

SURGE

80 ×0.6

PFM

Citations per year, relative to Afroditi Karathanasi Afroditi Karathanasi (= 1×) peers Georgia A. McCann

Countries citing papers authored by Afroditi Karathanasi

Since Specialization

Citations

This map shows the geographic impact of Afroditi Karathanasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afroditi Karathanasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afroditi Karathanasi more than expected).

Fields of papers citing papers by Afroditi Karathanasi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afroditi Karathanasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afroditi Karathanasi. The network helps show where Afroditi Karathanasi may publish in the future.

Co-authorship network of co-authors of Afroditi Karathanasi

This figure shows the co-authorship network connecting the top 25 collaborators of Afroditi Karathanasi. A scholar is included among the top collaborators of Afroditi Karathanasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afroditi Karathanasi. Afroditi Karathanasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Karathanasi, Afroditi, Aruni Ghose, Matin Sheriff, et al.. (2023). Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study. Cancers. 15(18). 4432–4432. 1 indexed citations

Shah, Sidrah, et al.. (2021). The Experience of a Single NHS England Trust on the Impact of the COVID-19 Pandemic on Junior and Middle-Grade Doctors: What Is Next?. International Journal of Environmental Research and Public Health. 18(19). 10413–10413. 12 indexed citations

Shah, Sidrah, Kathryn Lees, Charlotte Abson, et al.. (2021). Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK. Journal of Personalized Medicine. 11(2). 110–110. 10 indexed citations

Shah, Sidrah, et al.. (2021). Cancer-Associated Thrombosis: A New Light on an Old Story. SHILAP Revista de lepidopterología. 9(2). 34–34. 9 indexed citations

Ganesh, Vijayakumar, Afroditi Karathanasi, Michele Moschetta, et al.. (2021). Langerhans cell histiocytosis with spinal, pulmonary and pituitary involvement: What about ACTH deficiency without diabetes insipidus? A propos of a case.. PubMed. 25(2). 612–617. 2 indexed citations

Boussios, Stergios, Charlotte Abson, Michele Moschetta, et al.. (2020). Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond. Drugs in R&D. 20(2). 55–73. 103 indexed citations

Boussios, Stergios, Michele Moschetta, Peeter Karihtala, et al.. (2020). Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?. Annals of Translational Medicine. 8(24). 1706–1706. 18 indexed citations

Boussios, Stergios, Christos Mikropoulos, Eleftherios Pierre Samartzis, et al.. (2020). Wise Management of Ovarian Cancer: On the Cutting Edge. Journal of Personalized Medicine. 10(2). 41–41. 51 indexed citations

Boussios, Stergios, et al.. (2020). A narrative review of neoadjuvant, HIPEC and maintenance treatment in ovarian and peritoneal serous cancer: current status. 3. 19–19. 4 indexed citations

10.

Boussios, Stergios, Mehmet Akif Öztürk, Michele Moschetta, et al.. (2019). The Developing Story of Predictive Biomarkers in Colorectal Cancer. Journal of Personalized Medicine. 9(1). 12–12. 137 indexed citations

11.

Boussios, Stergios, Peeter Karihtala, Michele Moschetta, et al.. (2019). Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach. Investigational New Drugs. 38(1). 181–193. 80 indexed citations

12.

Boussios, Stergios, Peeter Karihtala, Michele Moschetta, et al.. (2019). Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review. Diagnostics. 9(3). 87–87. 117 indexed citations

13.

Boussios, Stergios, et al.. (2019). PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”. Diagnostics. 9(2). 55–55. 63 indexed citations

14.

Boussios, Stergios, et al.. (2018). Ovarian carcinosarcoma: Current developments and future perspectives. Critical Reviews in Oncology/Hematology. 134. 46–55. 47 indexed citations

15.

Boussios, Stergios, et al.. (2018). Metastatic Spinal Cord Compression: Unraveling the Diagnostic and Therapeutic Challenges. Anticancer Research. 38(9). 4987–4997. 55 indexed citations

16.

Boussios, Stergios, et al.. (2018). Spinal Ewing Sarcoma Debuting with Cord Compression: Have We Discovered the Thread of Ariadne?. Anticancer Research. 38(10). 5589–5597. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact